Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2004
06/17/2004US20040115775 Homogeneity and secretion of recombinant proteins in mammalian systems
06/17/2004US20040115773 Serpin in bifidobacteria
06/17/2004US20040115768 including culturing the cells at a temperature below 37 degrees C in a solution of mannose, galactose, or fructose; solution may be serum-free; genetic engineering
06/17/2004US20040115762 Comprises nucleotide sequences coding enzymatic polypeptide associated biosynthesis of nystatin and treatment of bacterial, fungal and parasitic infections; immunosuppressant; antitumor agents
06/17/2004US20040115743 Test kit for intracellular introduction of protein and/or peptide and method of intracellular introduction
06/17/2004US20040115704 Identifying, evaluating and characterizing activity of transcriptional control elements using expression vectors and/or reporter vectors providing kinetics of protein expression; drug screening and discovery
06/17/2004US20040115700 Comprises nucleotide sequences coding transcriptional splice variants of hippocampal and mammary gland negative regulatory protein for use in diagnosis and treatment of alzheimer's disease
06/17/2004US20040115697 Detecting tumors disorders via identifying centrosomal aberrations in microtubule organizing center of cell
06/17/2004US20040115695 Methods for generating enhanced antibody producing cell lines with improved growth characteristics
06/17/2004US20040115667 Dna-sequences, which code for an apoptosis signal transduction protein
06/17/2004US20040115666 Method for identifying compounds modulating reverse cholesterol transport
06/17/2004US20040115656 Androgen receptor down-regulatory-associated proteins(ARDAPs) for use in reduction of transactivation activity of androgen receptors and treatment of tumors; gene expression inhibition and anticarcinogenic agents
06/17/2004US20040115627 Genetically engineered cells comprising regulatory elements for use as tools in identifying compounds that alter protein expression: high throughput assay
06/17/2004US20040115306 Prolyl-specific endoprotease is added to the beverage
06/17/2004US20040115238 Muscle-polymer constructs for bone tissue engineering
06/17/2004US20040115224 Preparation and administration of hybrid cell vaccines for the prevention of cancer
06/17/2004US20040115220 Vaccine
06/17/2004US20040115216 Reagents and methods for engaging unique clonotypic lymphocyte receptors
06/17/2004US20040115202 monospecific antibody which specifically binds an epitope of a mammalian DPPIV (dipeptidyl peptidase IV, also known as CD26).
06/17/2004US20040115199 Method for down-regulating osteoprotegerin ligand activity
06/17/2004US20040115184 Methods and compositions for modifying apolipoprotein b mrna editing
06/17/2004US20040115176 Fibrin-based tissue-engineered vasculature
06/17/2004US20040115175 Methods for treating disorders of neuronal deficiency with bone marrow-derived cells
06/17/2004US20040115173 Method of treating inflammation, particularly diabetes
06/17/2004DE10255508A1 Verfahren zur Kultivierung von Zellen zur Produktion von Substanzen A method for culturing cells for the production of substances
06/17/2004CA2706873A1 Modified neomycin-phosphotransferase gene that increases expression rates of co-integrated gene and uses thereof
06/17/2004CA2508223A1 Germ-responsive promoter
06/17/2004CA2507395A1 Method for culturing neural stem cells using hepatocyte growth factor
06/17/2004CA2503973A1 Material compositions and related systems and methods for treating cardiac conditions
06/17/2004CA2485341A1 Use of spliceosome mediated rna trans-splicing to confer cell selective replication to adenoviruses
06/17/2004CA2469724A1 Mutant glycoproteins
06/17/2004CA2453387A1 Compositions and methods related to nitrotyrosine-containing compounds as antigenic agents
06/16/2004EP1428889A1 Method for monitoring the transition of a cell from one state into another
06/16/2004EP1428886A1 Improved retroviral vectors for gene therapy
06/16/2004EP1428883A1 Megakaryocyte stimulating factors
06/16/2004EP1428881A1 Hematopoietic stem cell proliferation regulators and polynucleotides encoding the same
06/16/2004EP1428880A1 Kidney-specific urate transporter and gene thereof
06/16/2004EP1428872A2 Tolerance-inducing thymus-bone marrow composite tissue construct and organ
06/16/2004EP1428871A1 Cultured cell construct containing spheroids of cultured animal cells and utilization thereof
06/16/2004EP1428834A1 Ligands for flt3 receptors
06/16/2004EP1427856A2 Fusion proteins useful for detecting analytes
06/16/2004EP1427841A2 Nucleic acid-associated proteins
06/16/2004EP1427838A1 Plant enzymes for bioconversion
06/16/2004EP1427836A2 Pseudotyped retroviral vector system
06/16/2004EP1427830A2 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY
06/16/2004EP1427828A2 Random integration of a polynucleotide after in vivo linearization
06/16/2004EP1427827A2 Synthetic hcv envelope proteins and their use for vaccination
06/16/2004EP1427825A2 Cdna encoding the human alpha2 delta4 calcium channel subunit
06/16/2004EP1427822A2 Nucleic acid for cloning vector
06/16/2004EP1427819A2 Lactobacillus n-deoxyribosyl transferases, corresponding nucleotide sequences and their uses
06/16/2004EP1427817A1 Multiplication of viruses in a cell culture
06/16/2004EP1427815A2 Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an mdck cell suspension culture
06/16/2004EP1427814A1 Pancreatic small cells and uses thereof
06/16/2004EP1427812A2 Production of cultured human mast cells and basophils for high throughput small molecule drug discovery
06/16/2004EP1427811A1 Erythrocytic cells and method for preserving cells
06/16/2004EP1427810A2 Method and quantification assay for determining c-kit/scf/pakt status
06/16/2004EP1427806A2 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
06/16/2004EP1427758A2 Compositions and methods of treating diabetes
06/16/2004EP1427754A1 Nucleic acid and polypeptide linked to breast cancer and uses therefor
06/16/2004EP1427753A2 Peptides and proteins binding to glu-pro motifs, therapeutical compositions containing them and their applications
06/16/2004EP1427750A1 Modified transferrin fusion proteins
06/16/2004EP1427742A1 Spider silk protein encoding nucleic acids, polypeptides, antibodies and method of use thereof
06/16/2004EP1427528A2 Plate and method for high throughput screening
06/16/2004EP1427462A1 Method for inducing selectively suppressed immune response
06/16/2004EP1427445A2 Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
06/16/2004EP1427405A2 Inflammation-inhibiting compounds
06/16/2004EP1427399A2 Retinoid receptor pan-antagonists for stimulating chondrogenesis
06/16/2004EP1427279A1 Preservation of non embryonic cells from non hematopoietic tissues
06/16/2004EP1301589A4 Culturing pancreatic stem cells having a specified, intermediate stage of development
06/16/2004EP1152767B1 Method for producing anti-tumor th1 cells
06/16/2004EP1127106A4 Glufosinate tolerant rice
06/16/2004EP1009844B1 IMPROVED $i(AGROBACTERIUM)-MEDIATED TRANSFORMATION OF PLANTS
06/16/2004EP1005540B1 Ikk-beta proteins, nucleic acids and methods
06/16/2004EP0892850A4 Immortalized hepatocytes
06/16/2004EP0847530B1 QUANTITATION OF p97 TO DIAGNOSE AND MONITOR ALZHEIMER'S DISEASE
06/16/2004EP0791078B1 Methods for drug screening
06/16/2004EP0787299B1 Receptor for a bacillus thuringiensis toxin
06/16/2004EP0672133B1 TNF-alpha RIBOZYMES AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-alpha RIBOZYMES
06/16/2004CN1505679A Alkaline protease variants, and detergents and cleaning agents containing the same
06/16/2004CN1505526A Compositions and methods for wt1 specific immunotherapy
06/16/2004CN1504752A Vaughan Tristan J.
06/16/2004CN1504477A Chicken polydactyly functional gene and uses thereof
06/16/2004CN1153833C Poplar chloroplast site-specific transformation method and DNA sequence for said method
06/16/2004CN1153792C Biological material embedded in hydrogels, process for embedding thereof, and its use as artificial seed
06/16/2004CN1153589C Treatment of infertility and enhancement of fertilization capacity in mammalian males
06/15/2004US6750378 Maize H3C4 promoter combined with the first intron of rice actin, chimeric gene comprising it and transformed plant
06/15/2004US6750327 Compositions and method for determining the presence of human PTTG peptide in a sample
06/15/2004US6750326 Method for separating cells using immunorosettes
06/15/2004US6750206 Recombinant nucleic acid vector comprising a nucleotide sequence encoding a syncytium-inducing polypeptide expressible on a eukaryotic cell surface
06/15/2004US6750196 Methods of treating disorders of the eye
06/15/2004US6750044 For producing pharmaceutically active materials having therapeutic and pharmacologic properties that differ from native vegf protein
06/15/2004US6750041 Homologous recombination antibody expression system for murine cells
06/15/2004US6750034 Useful as therapeutic agents for cancer, skin disorders, neuropathic pain, inflammatory, or coagulation diathesis/thrombosis; may also be useful for laundry detergents and skin care products; derived from humans
06/15/2004US6750021 Subtle mitochondrial mutations as tumor markers
06/15/2004US6750012 For identifying compounds that do not induce motor side effects
06/15/2004US6750009 Multiple viral replicon culture systems
06/15/2004US6749858 Nucleotide sequences coding polypeptide for use in the prevention of streptoccocus infection
06/15/2004US6749857 Recombinant dimeric envelope vaccine against flaviviral infection
06/10/2004WO2004048922A2 Bead-based detection of ligand-gpcr-g protein complexes
06/10/2004WO2004048601A2 Modulation of b7h expression